Contracts Finder · Award

CA15520 - NOROVIRUS

A public procurement published by University Hospitals of Derby and Burton NHS Foundation Trust via Contracts Finder.

Contracts FinderAward
£42.9k
Award value
Tender value
1
Suppliers
1
Awards
1
Notices
Award
Stage

Overview

NOROVIRUS DETECTION To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA15520. Not registered: Visit https://suppliers.multiquote.com then register and quote CA15520 as the reason for registration. Any queries please contact MultiQuote on 0151 482 9230.

Key details

Source
Contracts Finder
Lifecycle stage
Award
Status
complete
CPV classification
33696500 — Laboratory reagents
Currency
GBP
Total award value
£42,890
Tender value
First published
23 Apr 2025
Last updated
23 Apr 2025
View the original notice

Awards

1 award recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
R-Biopharm Rhone Ltd0194981222 Apr 2025active£42.9k

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Award noticeCA15520 - NOROVIRUS

All suppliers

Frameworks & programmes

More from University Hospitals of Derby and Burton NHS Foundation Trust

FAQs about this procurement

Who is the buyer for "CA15520 - NOROVIRUS"?

CA15520 - NOROVIRUS is a UK public-sector procurement published by University Hospitals of Derby and Burton NHS Foundation Trust via Contracts Finder.

Has "CA15520 - NOROVIRUS" been awarded?

Yes — 1 award is recorded, with a reported total value of £42,890. The current lifecycle stage is "Award".

Which suppliers are involved in "CA15520 - NOROVIRUS"?

1 supplier is linked: R-Biopharm Rhone Ltd.

What is "CA15520 - NOROVIRUS" worth?

The reported award value is £42,890.

When was "CA15520 - NOROVIRUS" published?

It was first published on 23 Apr 2025 and last updated on 23 Apr 2025, across 1 notice.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable